The Hon. (Dr.) Hansaka Wijemuni - Deputy Minister of Health and Mass Media
The Deputy Minister said the Government is developing infrastructure and zones, including Bingiriya, to support local pharmaceutical manufacturing and exports while attracting investors. Addressing the immunoglobulin procurement issue, he stated that existing testing and procurement procedures should prevent such incidents if followed, and that new measures and regulations have been introduced to avoid recurrence.
Verbatim record (translated)
Machine-translated from Sinhala / Tamil / English¶ 01 We are developing zones and infrastructure for local pharmaceutical manufacturing and export, including the Bingiriya zone, and encouraging investors. Regarding the immunoglobulin issue: Sri Lanka has established procurement and local purchasing procedures, and products must be tested under laboratory conditions before acceptance. If proper procedures are followed, issues like those with immunoglobulin should not occur; that incident arose because procedures were not followed. We have instituted measures and regulations to prevent recurrence.
Provenance
- Source
- Hansard, Friday, 20 June 2025 ·No. 1751600792021434 ·English daily/uncorrected Hansard
- Page · column
- not yet extracted — page/column anchors are not in the current dataset; the source PDF is the citable location.
- Permalink
/lk/speeches/1825
Cite as: The Hon. (Dr.) Hansaka Wijemuni - Deputy Minister of Health and Mass Media. 10th Parliament, Parliament of Sri Lanka. Hansard, 20 June 2025. No. 1751600792021434. Politick, https://staging.politick.io/lk/speeches/1825